seventy-one nonimmunocompromised patients with herpes zoster ophthalmicus , presenting within seven days of onset of characteristic skin eruption , were enrolled in a prospective , longitudinal , randomized , double-masked , placebo-controlled trial with oral acyclovir .
C0019364
herpes zoster ophthalmicus
C0001367
acyclovir